Ciprofloxacin/hydrocortisone

Last updated

Ciprofloxacin/hydrocortisone
Combination of
Ciprofloxacin Antibacterial
Hydrocortisone Anti-inflammatory
Clinical data
Trade names Cipro Hc
AHFS/Drugs.com Multum Consumer Information
MedlinePlus a607009
License data
Routes of
administration 		Auricular (otic)
ATC code
Legal status
Legal status
Identifiers
KEGG

Ciprofloxacin/hydrocortisone, sold under the brand name Cipro Hc among others is a fixed-dose combination medication used for the treatment of otitis externa. [1] [2] It contains ciprofloxacin, as the salt ciprofloxacin hydrochloride, an antibacterial; and hydrocortisone, an anti-inflammatory corticosteroid. [1]

Ciprofloxacin/hydrocortisone was approved for medical use in the United States in February 1998. [3]

Medical uses

Ciprofloxacin/hydrocortisone is indicated for the treatment of acute otitis externa due to susceptible strains of Pseudomonas aeruginosa , Staphylococcus aureus , and Proteus mirabilis . [1]

References

  1. 1 2 3 4 "Cipro Hc- ciprofloxacin hydrochloride and hydrocortisone suspension/ drops". DailyMed. 8 November 2024. Retrieved 11 November 2025.
  2. ↑ Beers SL, Abramo TJ (April 2004). "Otitis externa review". Pediatric Emergency Care. 20 (4): 250–256. doi:10.1097/01.pec.0000121246.99242.f5. PMID   15057182.
  3. ↑ "Drug Approval Package: Cipro HC Otic/Ciprofloxacin Hydrochloride & Hydrocortisone NDA# 20-805". U.S. Food and Drug Administration (FDA). 30 March 2001. Retrieved 11 November 2025.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.